Novartis nominates former Bristol Myers CEO Giovanni Caforio as its new chair. Will M&A deals follow?
Novartis nominates former Bristol Myers CEO Giovanni Caforio as its new chair. Will M&A deals follow?
aliu
СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *